AI Article Synopsis
- Composite hemangioendothelioma (CHE) is a rare and locally aggressive tumor that has an intermediate level of malignancy.
- The article discusses a 2-year-old patient who has been diagnosed with this type of tumor.
- Keeping detailed records of CHE patients is important for understanding their prognosis and figuring out the best treatment options.
Article Abstract
Composite hemangioendothelioma (CHE) is a rare locally aggressive vascular neoplasm of intermediate malignancy. We describe a 2-year-old patient diagnosed with this tumor. Careful documentation of patients with CHE is crucial to better define the prognosis and treatment of this entity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/pde.15725 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neurodevelopmental Effects of Propranolol Treatment During Infancy in Infantile Hemangioma Patients.
Children (Basel)
December 2024
Department of Pediatric Hematology and Oncology, Istanbul Medical Faculty, İstanbul University, 34098 Istanbul, Turkey.
Introduction And Aim: Propranolol is an effective treatment option for infantile hemangiomas, but there is still insufficient information about neurodevelopmental side effects of propranolol. In our study, the neurodevelopmental levels of infantile hemangioma patients receiving propranolol treatment were examined using the Bayley-III test.
Method: In our single-center, cross-sectional study, patients were recruited between 1 January 2020 and 31 December 2023.
A Rare Case With a Review of Cutaneous Composite Hemangioendothelioma and the Role of Neuroendocrine Markers.
Am J Dermatopathol
December 2024
Department of Pathology and Lab Medicine, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India; and.
Composite hemangioendothelioma comprises permutations of different histological patterns few of which have been found to have specific genetic alteration and immunohistochemical expression. It comprises retiform or epithelioid hemangioendothelioma-like areas, with a variable proportion of hemangioma or low-grade angiosarcoma-like areas. It was found to express neuroendocrine markers and was seen to have a worse prognosis in recurrence or distant metastasis.
View Article and Find Full Text PDFA Challenging Case of an Intraosseous Composite Hemangioendothelioma of the Occipital Bone With YAP1::FOXR1 Fusion.
Genes Chromosomes Cancer
December 2024
Department of Pathology, Ghent University Hospital, Ghent University, Ghent, Belgium.
Type and dimensions can predict ventricular arrhythmias and cardiac death in primary benign cardiac tumors in children.
Int J Cardiol
January 2025
Pediatric Cardiology and Cardiac Arrhythmias and Syncope Unit, Bambino Gesù Children's Hospital, IRCSS, 00146 Rome, Italy; European Reference Network for Low Prevalence and Rare Disease of the Heart- ERN Guard Heart, Italy. Electronic address:
Article Synopsis
- Primary benign cardiac tumors in children are rare but can lead to serious complications like malignant ventricular arrhythmias and cardiac death.
- A study conducted over 38 years included 97 children with various types of tumors, revealing that those with tumors larger than 2.3 cm or diagnosed with fibromas had worse health outcomes.
- The research highlighted that 24.5% of the patients experienced clinically significant arrhythmias, suggesting that tumor type and size are important indicators of potential risks.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!